Option Care Health, Inc. (NASDAQ:OPCH) Stock Has Average Price Target of $29.92 According to Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been assigned an average recommendation of “Hold” from the fifteen brokerages that are presently covering the company, MarketBeat.com reports. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $29.70.

OPCH has been the subject of several recent research reports. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $33.00 price objective on shares of Option Care Health in a research report on Wednesday. William Blair cut shares of Option Care Health from an “outperform” rating to a “market perform” rating in a report on Tuesday. Citizens Jmp reaffirmed a “market perform” rating on shares of Option Care Health in a research report on Wednesday. Finally, Truist Financial set a $32.05 target price on Option Care Health in a report on Wednesday.

Key Stories Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: The definitive acquisition agreement provides a clear cash valuation and near-term potential for shareholders, while the stock’s trading below the $32.05 offer price leaves a merger-arbitrage spread if the transaction closes as planned. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: Unusually heavy call-option activity and trading volume indicate significant speculative interest following the takeover announcement, although these signals do not guarantee additional gains. Option Care Health Rockets as CD&R and McKesson Table 37% Premium Bid
• Neutral Sentiment: JPMorgan reaffirmed a Neutral rating with a $33 price target, while Citizens JMP and Barrington Research maintained Market Perform ratings. The targets suggest limited upside beyond the announced offer and reflect the likelihood that the deal, rather than operating performance, will determine the stock’s value.
• Neutral Sentiment: Investors are booking gains and focusing on deal completion rather than standalone fundamentals. Zacks noted that recent earnings-estimate trends may not support further upside independent of the acquisition. Strength Seen in Option Care
• Negative Sentiment: Several shareholder-rights law firms are investigating whether the $32.05 offer fairly values Option Care Health and whether insiders received benefits unavailable to public shareholders. Such reviews could increase deal-related uncertainty or encourage demands for a higher bid. Ademi LLP OPCH Shareholder Alert

Institutional Trading of Option Care Health

A number of institutional investors have recently bought and sold shares of the company. Andina Capital Management LLC grew its stake in shares of Option Care Health by 2.6% during the fourth quarter. Andina Capital Management LLC now owns 16,320 shares of the company’s stock valued at $520,000 after purchasing an additional 419 shares during the last quarter. Pacer Advisors Inc. boosted its position in shares of Option Care Health by 1.3% in the 1st quarter. Pacer Advisors Inc. now owns 42,649 shares of the company’s stock worth $1,148,000 after purchasing an additional 528 shares during the last quarter. Central Pacific Bank Trust Division grew its position in shares of Option Care Health by 3.9% during the 3rd quarter. Central Pacific Bank Trust Division now owns 14,369 shares of the company’s stock worth $323,000 after buying an additional 540 shares during the period. State of Michigan Retirement System grew its holdings in Option Care Health by 1.6% during the first quarter. State of Michigan Retirement System now owns 38,159 shares of the company’s stock valued at $1,027,000 after purchasing an additional 600 shares during the period. Finally, Oregon Public Employees Retirement Fund grew its holdings in shares of Option Care Health by 2.5% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 32,530 shares of the company’s stock valued at $876,000 after buying an additional 800 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Up 0.0%

Option Care Health stock opened at $31.01 on Monday. Option Care Health has a 52 week low of $18.01 and a 52 week high of $36.80. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The stock has a market cap of $4.64 billion, a price-to-earnings ratio of 23.32, a PEG ratio of 1.79 and a beta of 0.58. The company’s 50-day moving average price is $23.92 and its two-hundred day moving average price is $23.57.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. During the same period in the prior year, the company earned $0.41 EPS. Option Care Health’s revenue was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, analysts expect that Option Care Health will post 1.7 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.